Inflammation in asthma: the cornerstone of the disease and target of therapy.

[1]  K. Chung,et al.  Cytokines in asthma , 1999, Thorax.

[2]  S. Holgate.  The rising trends in asthma , 1997 .

[3]  C. Bachert,et al.  Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. , 1997, Journal of immunology.

[4]  A. Leff,et al.  Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. , 1997, American journal of respiratory and critical care medicine.

[5]  S. Peters,et al.  Kinetics of the development and recovery of the lung from IgE-mediated inflammation: dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines. , 1997, American journal of respiratory and critical care medicine.

[6]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[7]  S. Holgate.  Asthma: a dynamic disease of inflammation and repair. , 1997, Ciba Foundation symposium.

[8]  D. Underwood,et al.  Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. , 1996, American journal of respiratory and critical care medicine.

[9]  D. Sampath,et al.  The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? , 1996, American journal of respiratory cell and molecular biology.

[10]  C. Page,et al.  Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. , 1996, The European respiratory journal.

[11]  J. Drazen,et al.  Sorting out the cytokines of asthma , 1996, The Journal of experimental medicine.

[12]  D. Yates,et al.  Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[13]  S. Wenzel,et al.  Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.

[14]  P. Howarth,et al.  Heterogeneity of human mast cells based on cytokine content. , 1995, Journal of immunology.

[15]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[16]  D. James,et al.  Are you TH‐l or TH‐2? , 1995 .

[17]  T. Schall,et al.  Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. , 1995, American journal of respiratory cell and molecular biology.

[18]  P. Barnes,et al.  Nitric oxide and asthmatic inflammation. , 1995, Immunology today.

[19]  P. O'Byrne,et al.  Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. , 1994, American journal of respiratory cell and molecular biology.

[20]  P. Barnes,et al.  Cytokines as mediators of chronic asthma. , 1994, American journal of respiratory and critical care medicine.

[21]  S. Spector,et al.  Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. , 1994, American journal of respiratory and critical care medicine.

[22]  M. Calderón,et al.  Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. , 1994, American journal of respiratory and critical care medicine.

[23]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[24]  I. Adcock,et al.  Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. , 1994, Immunology.

[25]  D. Postma,et al.  Early and late asthmatic reaction after allergen challenge. , 1994, Respiratory medicine.

[26]  W. Busse,et al.  The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma , 1993, Annals of Internal Medicine.

[27]  T. Takishima,et al.  The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. , 1993, The Journal of allergy and clinical immunology.

[28]  P. Barnes,et al.  Nitric oxide and lung disease. , 1993, Thorax.

[29]  S. Durham,et al.  Cytokines. 3. Cytokines in asthma. , 1993, Thorax.

[30]  A. Sousa,et al.  Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. , 1993, The American review of respiratory disease.

[31]  T. Haahtela,et al.  Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.

[32]  K. Chung,et al.  Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma. , 1993, The Journal of allergy and clinical immunology.

[33]  W. Timens,et al.  Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. , 1993, The American review of respiratory disease.

[34]  D. Margolskee,et al.  Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[35]  P. Jeffery,et al.  Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. , 1992, The American review of respiratory disease.

[36]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[37]  B. Schmekel,et al.  Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. , 1992, The European respiratory journal.

[38]  S. Romagnani.  Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? , 1992, Immunology today.

[39]  W. Busse,et al.  Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.

[40]  H. Kita,et al.  Glucocorticoids inhibit cytokine-mediated eosinophil survival. , 1991, Journal of immunology.

[41]  W. Roche.  Fibroblasts and asthma , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  R. Schleimer,et al.  Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. , 1991, Journal of immunology.

[43]  Paul H. Rubin,et al.  Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. , 1991, Thorax.

[44]  S. Wenzel,et al.  Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. , 1991, The Journal of allergy and clinical immunology.

[45]  H. Kita,et al.  Effect of steroids on immunoglobulin-induced eosinophil degranulation. , 1991, The Journal of allergy and clinical immunology.

[46]  E. R. Mcfadden,et al.  Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. , 1991, Annals of allergy.

[47]  S. Moncada,et al.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Moncada,et al.  Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. , 1990, Biochemical and biophysical research communications.

[49]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[50]  S. Wenzel,et al.  Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. , 1990, The American review of respiratory disease.

[51]  P. Bruijnzeel,et al.  Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate , 1990, British journal of pharmacology.

[52]  P. Sterk,et al.  The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. , 1990, The American review of respiratory disease.

[53]  R. Miesfeld.  Molecular genetics of corticosteroid action. , 1990, The American review of respiratory disease.

[54]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[55]  L. Lichtenstein,et al.  Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. , 1989, The American review of respiratory disease.

[56]  L. Frølund,et al.  A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. , 1989, The Journal of allergy and clinical immunology.

[57]  O. Burghuber,et al.  Long-term treatment with disodium cromoglycate does not alter bronchial hyperreactivity in patients with perennial bronchial asthma. , 1989, Respiration; international review of thoracic diseases.

[58]  N. Thomson.  Nedocromil sodium: an overview. , 1989, Respiratory medicine.

[59]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[60]  P. Bruijnzeel,et al.  Nedocromil sodium inhibits the A23187‐ and opsonized zymosan‐induced leukotriene formation by human eosinophils but not by human neutrophils , 1989, British journal of pharmacology.

[61]  R. Stenling,et al.  Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. , 1988, The European respiratory journal.

[62]  S. Wenzel,et al.  Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. , 1988, The American review of respiratory disease.

[63]  P. O'Byrne,et al.  Late asthmatic responses. , 1987, The American review of respiratory disease.

[64]  P. O'Byrne,et al.  Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. , 1987, The American review of respiratory disease.

[65]  A. Kay,et al.  Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. , 1987, The Journal of allergy and clinical immunology.

[66]  S. Wasserman,et al.  Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow. , 1986, The American review of respiratory disease.

[67]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[68]  N. Johnson,et al.  Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. , 1985, Clinical science.

[69]  A. B. Kay,et al.  Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. , 1984, The Journal of allergy and clinical immunology.

[70]  A. Kay,et al.  Preferential generation of leukotriene C4 by human eosinophils. , 1984, Clinical and experimental immunology.

[71]  L. A. Cupples,et al.  Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. , 1983, The American journal of medicine.

[72]  S. Peters,et al.  Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. , 1983, The Journal of clinical investigation.

[73]  M. Church,et al.  The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine , 1983, British journal of pharmacology.

[74]  J. Gauldie,et al.  Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. , 1982, Journal of immunology.

[75]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.

[76]  M. Dunnill.  THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA , 1960, Journal of clinical pathology.